
Scott Howell, DO, MPH & TM, CPE, Advisor to Echosens, was featured in OncologyTube interview: “Underlying Nonalcoholic Fatty Liver Disease is a Significant Factor for Breast Cancer Recurrence After Curative…
Discussions and articles surrounding trending topics in the liver industry
Scott Howell, DO, MPH & TM, CPE, Advisor to Echosens, was featured in OncologyTube interview: “Underlying Nonalcoholic Fatty Liver Disease is a Significant Factor for Breast Cancer Recurrence After Curative…
The prevalence of non-alcoholic fatty liver disease (NAFLD) has reached epidemic levels. The most common liver disease, with a worldwide prevalence of 25%, NAFLD and its subtype, nonalcoholic steatohepatitis (NASH),…
Join us in supporting World Diabetes Day, November 14, 2020, and National Diabetes Month this November! Echosens recognizes the importance of World Diabetes Day (WDD) and National Diabetes Month, and…
Join us in supporting Veterans Day, Nov. 11, 2020! Echosens is recognizing the importance of Veterans Day by celebrating the Department of Veterans Affairs’ (VA) victory in the battle against…
Echosens new Spleen Stiffness Measurement (SSM by VCTE™) delivers risk stratification of patients with cirrhosis and those with portal hypertension at risk for decompensation Superior to Liver Biopsy Liver…
Echosens Introduces FibroScan 630 Expert: Adds New Spleen Stiffness Measurement (SSM by VCTE™) for Risk Stratification of Patients with Advanced Chronic Liver Disease Waltham, MA – November 9, 2020 – Echosens,…
Echosens recognizes November 2-6, 2020 as Obesity Week and the dedicated professionals at the Obesity Society who are collaborating to overcome obesity. During this week, Echosens points to the link…
Join us in supporting October 2020 Liver Cancer Awareness Month In the spirit of Liver Cancer Awareness Month this October, Echosens would like to highlight some alarming trends to help…
Self-Insured Employers Can Boost Workforce Productivity, Reduce Medical Costs Download our latest white paper: “Comprehensive Chronic Care Disease Management of Liver Disease Improves Member Outcomes, Reduces Costs for Employer-…
NASH Network (NASHNET), a global network of thought leaders dedicated to advancing care pathways for nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH), has published a novel cost-effectiveness analysis…